Domov › Rak mehurja › Minnesota

Klinične študije za Rak mehurja v Minnesota

24 študij za Rak mehurja išče udeležence na lokacijah v Minnesota.

Mesta v Minnesota

Uradno besedilo študije (angleško)

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Mayo Clinic in Rochester, Rochester

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07000084

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Riverwood Healthcare Center, Aitkin
Mayo Clinic Health System in Albert Lea, Albert Lea
Essentia Health - Baxter Clinic, Baxter
in še 48

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Essentia Health Saint Joseph's Medical Center, Brainerd
Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
in še 5

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06770582

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Mayo Clinic in Rochester, Rochester

Vključevanje udeležencevFaza 4

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06764095

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Health Partners Frauenshuh Cancer Center, Saint Louis Park
Health Partners Cancer Center at Regions Hospital, Saint Paul

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Sanford Joe Lueken Cancer Center, Bemidji
Fairview Southdale Hospital, Edina
Abbott-Northwestern Hospital, Minneapolis
in še 1

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
Fairview Southdale Hospital, Edina
in še 8

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT03866382

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Mayo Clinic Rochester, Rochester

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07277413

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Minnesota Oncology and Hematology PA, Minneapolis

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT05267626

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Mayo Clinic (Rochester), Rochester

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Mayo Clinic Rochester, Rochester
Minnesota Urology, Woodbury

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06567743

The Vanguard Study: Testing a New Way to Screen for Cancer

Minneapolis VA Medical Center, Minneapolis

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 45–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06995898

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Minnesota Urology, Woodbury, Bloomington
Mayo Clinic, Rochester

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT05951179

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Minnesota Oncology - Burnsville, Burnsville
Mercy Hospital, Coon Rapids
Fairview Southdale Hospital, Edina
in še 16

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07097142

Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy

Mayo Clinic in Rochester, Rochester

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06891209

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

University of Minnesota, Minneapolis
Mayo Clinic, Rochester

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT04752722

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

St. Luke's Hospital, Duluth

Vključevanje udeležencevFaza 2

Starost 8 in več · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT05503797

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Allina Health Cancer Institute - Mercy Hospital, Coon Rapids
Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Allina Health Cancer Institute - United Hospital, Saint Paul
in še 1

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT04389632

Integrated Cancer Repository for Cancer Research

Riverwood Healthcare Center, Aitkin
Essentia Health-St. Joseph's Medical Center, Brainerd
Essentia Health - Duluth Clinic, Duluth
in še 2

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Mayo Clinic in Rochester, Rochester

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 8. maj 2026 · NCT07087860

Bladder Bank (a Prospective Banking Study)

Mayo Clinic in Rochester, Rochester

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 16. mar. 2026 · NCT06109857

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Allina Health Cancer Institute, Minneapolis
Mayo Clinic, Rochester

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 40 in več · Vsi spoli · Posodobljeno 20. jan. 2026 · NCT05366881

Blue Light Cystoscopy With Cysview® Registry

University of Minnesota, Minneapolis

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 18. dec. 2025 · NCT02660645

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duluth

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.